1. Home
  2. ALLY vs RGEN Comparison

ALLY vs RGEN Comparison

Compare ALLY & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALLY
  • RGEN
  • Stock Information
  • Founded
  • ALLY 1919
  • RGEN 1981
  • Country
  • ALLY United States
  • RGEN United States
  • Employees
  • ALLY N/A
  • RGEN N/A
  • Industry
  • ALLY Major Banks
  • RGEN Medical/Dental Instruments
  • Sector
  • ALLY Finance
  • RGEN Health Care
  • Exchange
  • ALLY Nasdaq
  • RGEN Nasdaq
  • Market Cap
  • ALLY 11.3B
  • RGEN 9.1B
  • IPO Year
  • ALLY 2014
  • RGEN N/A
  • Fundamental
  • Price
  • ALLY $37.50
  • RGEN $158.99
  • Analyst Decision
  • ALLY Buy
  • RGEN Buy
  • Analyst Count
  • ALLY 20
  • RGEN 11
  • Target Price
  • ALLY $43.12
  • RGEN $180.63
  • AVG Volume (30 Days)
  • ALLY 3.1M
  • RGEN 627.3K
  • Earning Date
  • ALLY 04-17-2025
  • RGEN 02-20-2025
  • Dividend Yield
  • ALLY 3.20%
  • RGEN N/A
  • EPS Growth
  • ALLY N/A
  • RGEN N/A
  • EPS
  • ALLY 1.80
  • RGEN N/A
  • Revenue
  • ALLY $6,816,000,000.00
  • RGEN $634,439,000.00
  • Revenue This Year
  • ALLY N/A
  • RGEN $2.28
  • Revenue Next Year
  • ALLY $9.08
  • RGEN $9.69
  • P/E Ratio
  • ALLY $20.94
  • RGEN N/A
  • Revenue Growth
  • ALLY N/A
  • RGEN 0.33
  • 52 Week Low
  • ALLY $31.95
  • RGEN $113.50
  • 52 Week High
  • ALLY $45.46
  • RGEN $203.13
  • Technical
  • Relative Strength Index (RSI)
  • ALLY 46.15
  • RGEN 53.41
  • Support Level
  • ALLY $36.75
  • RGEN $143.83
  • Resistance Level
  • ALLY $39.45
  • RGEN $169.00
  • Average True Range (ATR)
  • ALLY 0.90
  • RGEN 5.95
  • MACD
  • ALLY -0.07
  • RGEN -0.24
  • Stochastic Oscillator
  • ALLY 27.59
  • RGEN 61.46

About ALLY Ally Financial Inc.

Formerly the captive financial arm of General Motors, Ally Financial became an independent publicly traded firm in 2014 and is one of the largest consumer auto lenders in the country. While the firm has expanded its product offerings over time, it remains primarily focused on auto lending with more than 70% of its loan book in consumer auto loans and dealer financing. Ally also offers auto insurance, commercial loans, credit cards, and holds a portfolio of mortgage debt, giving the bank a diversified business model, which includes brokerage services.

About RGEN Repligen Corporation

Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 54% of 2023 revenue, while chromatography, proteins, and process analytics were 20%, 16%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.

Share on Social Networks: